vTv Therapeutics Inc. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
vTv Therapeutics Inc. (VTVT) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$4.56 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2022-11-10
- vTv Therapeutics Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2022-09-30 was -$1.21M.
- vTv Therapeutics Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-09-30 was -$378.00K.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month |
|---|---|---|---|
| 2022-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$4.56M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$3.36M 10-Q · filed 2022-08-15 | ||
| 2021-09-30 | -$378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.31M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$1.93M 10-Q · filed 2022-08-15 |